20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

Clinical trial NCT04530838 · COMPLETED

Trial details

NCT number: NCT04530838
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease

Start date: 2020-09-16
Primary completion: 2022-04-02
Enrollment: 668

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.